non-survivor – Page 18 – Communicable Diseases Research

Neutrophil-to-Lymphocyte, Lymphocyte-to-Monocyte, and Platelet-to-Lymphocyte Ratios: Prognostic Significance in COVID-19

Internal Medicine

Published on 2021-01-112022-10-31
Journal: Cureus [Category] COVID-19,

Risk factors for mortality of critically ill patients with COVID-19 receiving invasive ventilation

Observational Study

Published on 2021-01-112022-10-04
Journal: International Journal of Medical Sciences [Category] MERS, 임상,

Clinical characteristics and predictors of mortality in young adults with severe COVID-19: a retrospective observational study

Observational Study

Published on 2021-01-062022-10-04
Journal: Annals of Clinical Microbiology and Antimicrobials [Category] MERS, 임상,

[키워드] abnormality Analysis analyzed C-reactive protein cardiac troponin Characteristics clinical Clinical characteristics Clinical outcome COVID-19 death Dyspnea elder patients electronic medical records elevated Factor hypersensitive incidence independent predictor Laboratory laboratory abnormalities Logistic regression analysis logistic regression model lymphopenia Mortality multivariate non-survivor outcome pathogenesis of COVID-19 Patient predicted Predictive predictor predictors prognostic effect recruited Result retrospective retrospective cohort SARS-CoV-2 sensitivity severe severe COVID-19 survival Tongji Hospital Treatment variable young adults
[DOI] 10.1186/s12941-020-00412-9 PMC 바로가기 [Article Type] Observational Study

Predictors of Poor Outcomes for COVID-19-Associated Pneumonia in a Minority Population

Internal Medicine

Published on 2021-01-022022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] Admission age C-reactive protein China city Clinical characteristics correlation COVID-19 COVID-19 diagnosis COVID-19 infection D-dimer D-dimer level demonstrated died etiology ferritin Healthcare provider high-risk population Hospital stay ICU increased mortality infected patients Inflammatory marker Intubated intubation Laboratory lactate dehydrogenase minority population New York City non-survivor Novel coronavirus objective outbreak outcome pandemic Patient Pneumonia Poor Population predict predictors procalcitonin proportion Result significant difference significantly higher statistically significant difference study population survivor Survivors the patient WHO World Health Organization Wuhan
[DOI] 10.7759/cureus.12431 PMC 바로가기 [Article Type] Internal Medicine

Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis

코로나19 환자에서 울혈성 심부전의 영향과 심장 바이오마커의 역할: 체계적인 검토 및 메타 분석

Meta-Analysis

Published on 2021-01-012022-08-31
Journal: Indian heart journal [Category] MERS, SARS, 바이오마커,

[키워드] 95% CI Acute cardiac injury appear Biomarker Biomarkers BNP cardiac Cardiac arrhythmia cardiac arrhythmias Cardiac biomarkers cardiac injury cardiovascular comorbidities cardiovascular disease CK-MB collected conducted congestive heart failure coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients database Deceased determined by disease severity elevated Google Scholar hypertension identify Impact in-hospital mortality increased risk mean difference Meta-analysis Mortality mortality risk non-survivor NT-proBNP outcome outcomes Patient paucity of data Prognosis Relative risk reported risk risk factor Risk factors selected severe disease severely infected patients significantly survival systematic review troponin Troponin-I was used
[DOI] 10.1016/j.ihj.2020.12.002 PMC 바로가기 [Article Type] Meta-Analysis

Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis

COVID-19의 심각도 및 사망률에 대한 잠재적 바이오마커로서 Interleukin-6 및 Interleukin-10의 순환 수준(종양 괴사 인자-알파 아님): 메타 분석을 통한 체계적 검토

Meta-Analysis

Published on 2021-01-012022-09-11
Journal: Journal of Clinical Immunology [Category] SARS, 바이오마커,

[키워드] 95% CI acute respiratory distress Alpha association Biomarker Biomarkers circulating Cochrane Library contributing to COVID-19 COVID-19 mortality COVID-19 patient COVID-19 patients cytokine Cytokine storm Cytokines database determine disease severity elevated eligible hand highlighting IL-10 IL-6 inception Inflammatory cytokine Inflammatory cytokines interleukin interleukin-10 interleukin-6 Level manifestation mean difference Meta-analysis meta-regression Mortality non-survivor performed Potential publication bias Quality random-effects model Regression respiratory distress review Sensitivity analyses sensitivity analysis severe COVID-19 patient severe COVID-19 patients severe manifestations of COVID-19 severity significantly significantly increased survivor syndrome systematic review systemic inflammatory response systemic level the disease therapeutic target TNF-α Tumor tumor necrosis tumor necrosis factor tumor necrosis factor-alpha was performed
[DOI] 10.1007/s10875-020-00899-z PMC 바로가기 [Article Type] Meta-Analysis

Characteristics of coagulation alteration in patients with COVID-19

Clinical Trial

Published on 2021-01-012022-10-05
Journal: Annals of Hematology [Category] SARS, 임상,

[키워드] abnormal coagulation accompanied Admission Affect AUC Blood coagulation changes in characteristic Coagulation coagulation parameter coronavirus disease COVID-19 critically ill patients D-dimer death Degradation died hospital implication In-hospital death INR International investigated Logistic regression Mortality multivariate no significant difference non-survivor normalized occur PaO Patient patients with COVID-19 predict Primary outcome Prognosis prothrombin Prothrombin time Prothrombin time activity. Record Retrospective study significantly significantly higher surviving patient Survivors Treatment with COVID-19
[DOI] 10.1007/s00277-020-04305-x PMC 바로가기 [Article Type] Clinical Trial

Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis

중증 코로나19 환자의 인터루킨-6: 후향적 분석

Clinical Trial

Published on 2020-12-312022-08-13
Journal: PLoS ONE [Category] Biochemistry, MERS, SARS, 임상,

[키워드] Admission admitted patients AUROC Blood Blood cells blood concentration C-reactive protein China clinician collected Concentration conducted coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 patient Critically ill critically ill COVID-19 patients cytokine Cytokine storm D-dimers demographic diagnosis of COVID-19 disease evaluate ferritin help highest ICU IL-6 IL-6 level intensive care unit interleukin-6 Interleukine-6 laboratory data Lactate lactate dehydrogenase LDH lymphocyte Lymphocytes Mortality non-survivor outcome parameter pathophysiology Patient patients patients with COVID-19 poor prognosis Predictive Predictive value repeated Result Retrospective analysis Retrospective study risk severity significant difference significantly higher Spread survivor White blood cell White blood cells
[DOI] 10.1371/journal.pone.0244628 PMC 바로가기 [Article Type] Clinical Trial

SARS-CoV-2 PCR cycle threshold at hospital admission associated with patient mortality

Observational Study

Published on 2020-12-312022-10-04
Journal: PLoS ONE [Category] MERS, SARS, 임상,

[키워드] 48 hour acute respiratory syndrome adjusted odds ratio Admission age Analysis analyzed applied AUC BMI Clinical data clinically competing Complete conducted continuous variable coronavirus cumulative incidence cycle threshold death diabetes died discharge discharged disease disease severity electronic medical records Gender hospital Hospital admission hospitalized patient hypertension in-hospital mortality independent information initial investigated Logistic regression Mortality non-survivor outcome Patient patient mortality positive predict quartile Retrospective study risk Risk factors SARS-CoV-2 SARS-CoV-2 PCR significantly specimen suggested survival survivor utility Variation viral burden
[DOI] 10.1371/journal.pone.0244777 PMC 바로가기 [Article Type] Observational Study

COVID-19 disease—Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study

COVID-19 질병 - 질병 경과에 따른 완전한 혈구 수 매개변수의 시간적 분석, 생존자 및 비생존자의 환자 인구 통계 및 관리 결과와의 관계: 종단적 기술 코호트 연구

Research Article

Published on 2020-12-282022-09-10
Journal: PLoS ONE [Category] MERS, 바이오마커,

[키워드] 95% CI 95%CI Acute inflammation age analysed Analysis anisocytosis ANOVA average Biomarkers Blood blood cell blood cell count blood count cardiovascular disease cardiovascular diseases carried CBC Cell chronic renal failure Clinical outcome co-morbidities co-morbidity cohort study Complete complete blood count Concentration confounding effect continuous variable continuous variables COPD Course COVID-19 COVID-19 disease COVID-19 patient COVID19 death demographics diabetes disease distribution enrolled estimates Evolution Gender Haemoglobin identify Increased Infectious diseases Inpatient Inpatients Italian Italy joint later phase longitudinal cohort study lymphocyte lymphocyte counts Lymphocytes management mean platelet volume measure median Monocytes morbidities neutrophil neutrophil counts Neutrophils non-survivor Non-survivors obesity outcome p-values parameter parameters Patient patient age patients with diabete performed Platelet Platelets prognostic prognostic indicator red blood cell red blood cell count reduced renal renal failure Rome significantly significantly higher Stata statistical survivor Symptoms Volume with COVID-19
[DOI] 10.1371/journal.pone.0244129 PMC 바로가기 [Article Type] Research Article